The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from ...

Bexhill’s De La Warr Pavilion presents Ssh Ow, the first major solo exhibition in a UK public gallery in a decade by ...

Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...

U.S. involvement in WHO flu meetings, the UK's approval of Moderna's RSV vaccine, efforts against a measles outbreak in Texas ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Wacky Bob Kennedy and the health officials who work for him are now reevaluating a $590 million contract for bird flu shots ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...